Bromodomain factor 5 is an essential regulator of transcription in Leishmania

Jones, Nathaniel G. orcid.org/0000-0001-7328-4487, Geoghegan, Vincent, Moore, Gareth et al. (9 more authors) (2022) Bromodomain factor 5 is an essential regulator of transcription in Leishmania. Nature Communications. 4071. ISSN 2041-1723

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

Funding Information: This work was supported by funding from GSK through the Pipeline Futures Group and a Fellowship from a Research Council United Kingdom Grand Challenges Research Funder under grant agreement ‘A Global Network for Neglected Tropical Diseases’ grant number MR/P027989/1. to Nathaniel Jones. This work was part-funded by the Wellcome Trust [ref: 204829] through the Centre for Future Health (CFH) at the University of York. Elmarie Myburgh, University of York, assisted with lymph-node dissection and parasite burden assays. We thank our colleagues in The Bioscience Technology Facility of the University of York, who provided expertise and technical support that assisted this work, and Robert Kirkpatrick (former GSK employee) for his critical input to develop the collaboration between University of York and GSK. Funding Information: This work was supported by funding from GSK through the Pipeline Futures Group and a Fellowship from a Research Council United Kingdom Grand Challenges Research Funder under grant agreement ‘A Global Network for Neglected Tropical Diseases’ grant number MR/P027989/1. to Nathaniel Jones. This work was part-funded by the Wellcome Trust [ref: 204829] through the Centre for Future Health (CFH) at the University of York. Elmarie Myburgh, University of York, assisted with lymph-node dissection and parasite burden assays. We thank our colleagues in The Bioscience Technology Facility of the University of York, who provided expertise and technical support that assisted this work, and Robert Kirkpatrick (former GSK employee) for his critical input to develop the collaboration between University of York and GSK. Publisher Copyright: © 2022, The Author(s).

Dates:
  • Published: 13 July 2022
  • Accepted: 30 June 2022
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Centre for Immunology and Infection (CII) (York)
The University of York > Faculty of Sciences (York) > Biology (York)
The University of York > Faculty of Sciences (York) > Hull York Medical School (York)
The University of York > Faculty of Sciences (York) > Chemistry (York)
Depositing User: Pure (York)
Date Deposited: 28 Jul 2022 08:30
Last Modified: 23 Jan 2025 00:30
Published Version: https://doi.org/10.1038/s41467-022-31742-1
Status: Published
Refereed: Yes
Identification Number: 10.1038/s41467-022-31742-1
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Filename: s41467_022_31742_1.pdf

Description: Bromodomain factor 5 is an essential regulator of transcription in Leishmania

Licence: CC-BY 2.5

Export

Statistics